Allarity Therapeutics Statistics
Total Valuation
ALLR has a market cap or net worth of $19.40 million. The enterprise value is $1.14 million.
Important Dates
The next estimated earnings date is Tuesday, May 13, 2025, after market close.
Earnings Date | May 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
ALLR has 17.01 million shares outstanding.
Current Share Class | 17.01M |
Shares Outstanding | 17.01M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +174.87% |
Owned by Insiders (%) | 0.00% |
Owned by Institutions (%) | 0.67% |
Float | 17.01M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.70 |
P/TBV Ratio | 1.64 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.11.
Current Ratio | 2.06 |
Quick Ratio | 2.01 |
Debt / Equity | 0.11 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -26.86 |
Financial Efficiency
Return on equity (ROE) is -541.17% and return on invested capital (ROIC) is -187.21%.
Return on Equity (ROE) | -541.17% |
Return on Assets (ROA) | -63.52% |
Return on Invested Capital (ROIC) | -187.21% |
Return on Capital Employed (ROCE) | -148.49% |
Revenue Per Employee | n/a |
Profits Per Employee | -$3.59M |
Employee Count | 7 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -381,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.39% in the last 52 weeks. The beta is -0.07, so ALLR's price volatility has been lower than the market average.
Beta (5Y) | -0.07 |
52-Week Price Change | -97.39% |
50-Day Moving Average | 0.93 |
200-Day Moving Average | 2.08 |
Relative Strength Index (RSI) | 62.67 |
Average Volume (20 Days) | 1,287,218 |
Short Selling Information
The latest short interest is 1.45 million, so 8.53% of the outstanding shares have been sold short.
Short Interest | 1.45M |
Short Previous Month | 1.20M |
Short % of Shares Out | 8.53% |
Short % of Float | 8.53% |
Short Ratio (days to cover) | 0.78 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -17.54M |
Pretax Income | n/a |
Net Income | -25.15M |
EBITDA | -17.53M |
EBIT | -17.54M |
Earnings Per Share (EPS) | -$15.65 |
Full Income Statement Balance Sheet
The company has $19.61 million in cash and $1.35 million in debt, giving a net cash position of $18.26 million or $1.07 per share.
Cash & Cash Equivalents | 19.61M |
Total Debt | 1.35M |
Net Cash | 18.26M |
Net Cash Per Share | $1.07 |
Equity (Book Value) | 11.81M |
Book Value Per Share | 1.62 |
Working Capital | 11.50M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$17.35 million and capital expenditures -$298,000, giving a free cash flow of -$17.65 million.
Operating Cash Flow | -17.35M |
Capital Expenditures | -298,000 |
Free Cash Flow | -17.65M |
FCF Per Share | -$1.04 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |